Aura Biosciences Inc
AURA
Get informed when a big investor buys or sells
+ FollowMarket Cap$826.46M
Close$
$0.70
90.9% downside
Current Fair Value
90.9% downsideOvervalued by 90.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $826.46 Million |
|---|---|
| Enterprise Value | $775.21 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.76 |
| Beta | 0.4 |
| Outstanding Shares | 67,447,576 |
Return
| Return on Equity | -41.56% |
|---|---|
| Return on Assets | -37.63% |
| Return on Invested Capital | -0.34% |
Valuation & Multiples
| P/E Ratio | -4.51 |
|---|---|
| PEG | -6.55 |
| Price to Sales | - |
| Price to Book Ratio | 1.91 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -701.55 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.38
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.37
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.35%▼ 68.98% |
|---|---|
| Total Invested | $73.48M▼ 78.41% |
| Investors Holding | 40▼ 87.00% |
ESG Score
No data